What is well-differentiated squamous cell carcinoma?
Mar 04, 2022
Source: Cainiu Health
Dr. Zhou Maoxin
Introduction
Some clinical patients may ask questions like this: First, what is squamous cell carcinoma? Squamous cell carcinoma is a type of tumor. A small tissue sample is surgically removed and sent to the pathology department for examination. Under the microscope, pathologists observe that the tumor cells exhibit characteristics of squamous cells—hence the term “squamous cell carcinoma.” Thus, it is a classification based on the cellular origin of the tumor.
Some patients in clinical practice ask questions like this: “Doctor, what is well-differentiated squamous cell carcinoma?” In fact, this question can be addressed from two perspectives. So, what exactly is well-differentiated squamous cell carcinoma? Below, we provide a detailed explanation.
What Is Well-Differentiated Squamous Cell Carcinoma?
First, what is squamous cell carcinoma? Squamous cell carcinoma is a type of tumor. A small tissue sample is surgically removed and sent to the pathology department for examination. Under the microscope, pathologists observe that the tumor cells resemble normal squamous epithelial cells—hence the term “squamous cell carcinoma.” Thus, it denotes a specific cellular origin of the malignancy.
Second, what does “well-differentiated” mean? All tumors—including squamous cell carcinomas, adenocarcinomas, and others—can be classified as well-differentiated, moderately differentiated, poorly differentiated, or undifferentiated. Generally, the higher the degree of malignancy, the poorer the differentiation (i.e., poorly differentiated); conversely, lower malignancy correlates with better differentiation (i.e., well-differentiated).
In summary, “well-differentiated squamous cell carcinoma” refers to a malignant tumor arising from squamous epithelial cells, exhibiting relatively preserved cellular architecture and function—indicating a comparatively favorable prognosis.
What Should Be Done If Squamous Cell Carcinoma Antigen (SCC) Levels Are Elevated?
1. Repeat Testing: Patients should undergo retesting within 1–2 weeks. If SCC levels remain elevated, contrast-enhanced CT scans of the chest, abdomen, and pelvis are recommended. When feasible, PET-CT may further aid evaluation. Persistently rising SCC levels often indicate an underlying malignancy, and early intervention generally yields better outcomes.
2. Monitoring: Elevated serum SCC levels are observed in approximately 83% of cervical cancers, 25%–75% of pulmonary squamous cell carcinomas, 30% of stage I esophageal cancers, and 89% of stage III esophageal cancers. Elevated SCC may also occur in ovarian cancer, endometrial cancer, and head-and-neck squamous cell carcinomas. Clinically, serial SCC measurements are commonly used to monitor disease progression and treatment response.
We hope the above information is helpful to you.
